Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment
Open Access
- 12 November 2019
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 11 (21), 9328-9347
- https://doi.org/10.18632/aging.102373
Abstract
In the microenvironment of breast cancer, immune cell infiltration is associated with an improved prognosis. To identify immune-related prognostic markers and therapeutic targets, we determined the lymphocyte-specific kinase (LCK) metagene scores of samples from breast cancer patients in The Cancer Genome Atlas. The LCK metagene score correlated highly with other immune-related scores, as well as with the clinical stage, prognosis and tumor suppressor gene mutation status (BRCA2, TP53, PTEN) of patients in the four breast cancer subtypes. A weighted gene co-expression network analysis was performed to detect representative genes from LCK metagene-related gene modules. In two of these modules, the levels of the co-expressed genes correlated highly with LCK metagene levels, so we conducted an enrichment analysis to discover their functions. We also identified differentially expressed genes in samples with high and low LCK metagene scores. By examining the overlapping results from these analyses, we obtained 115 genes, and found that 22 of them were independent predictors of overall survival in breast cancer patients. These genes were validated for their prognostic and diagnostic value with external data sets and paired tumor and non-tumor tissues. The genes identified herein could serve as diagnostic/prognostic markers and immune-related therapeutic targets in breast cancer.Keywords
This publication has 44 references indexed in Scilit:
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancerClinical and Translational Oncology, 2014
- CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer modelImmunology, 2014
- C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patientsBreast Cancer Research and Treatment, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infectionNature, 2013
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersBMC Cancer, 2007
- An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4The Journal of Experimental Medicine, 2003
- Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective allelesProceedings of the National Academy of Sciences of the United States of America, 2000